Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3644-3651
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3644
Table 1 Patient and tumor characteristics
CharacteristicMedianRange
Age (yr)6430-82
Tumor size (mm)3510-90
N (n = 26)
Gender
M1973%
F727%
Tumor location
Cardia831%
Corpus623%
Antrum1246%
Tumor pT stage
pTx28%
pT1519%
pT2519%
pT31039%
pT4415%
Type of resection
Total gastrectomy1142%
Partial gastrectomy1454%
No resection14%
Preoperative CTx2388%
Table 2 Characteristics of detected sentinel lymph nodes
PatientNo.T stageTumorlocationPre-operativeCTxNumber of detected SLNsLocation of detected SLNs by LN StMean SBRof SLNsTumorstatus inSLNsSLNIdentificationaccurate?SLN outsideStandarddissection plane?
11MNo335.4NegYesNo
24MYes33; 3 and 61.9PosNoNo
34DYesNo tracer injected because of metastasized disease
41DYes34; 6 and 64.3NegYesNo
52UYes43; 3; 4 and 43.9NegYesNo
63MYes34; 4 and 75.3NegYesNo
71MNo43; 3; 6 and 63.1NegYesNo
82UYesTechnical failure of tracer administration
93UYes21 and 18.7NegYesNo
103DNo36; 6 and 124.7PosNoYes
113DYes45; 6; 6 and 124.9PosYesYes
124UYesNo tracer injected because of metastasized disease
132UYes31; 7 and 93.5NegYesNo
142DYes46 and 125.1PosYesYes
152MYes0NANANANANo
164MYesNo tracer injected because of metastasized disease
173UYes28 and 122.6NegYesYes
183DYes25 and 611.4NegYesNo
19xDYes23 and 33.6NegYesNo
20xDYes23 and 143.6NegYesYes
213MYes53; 3; outside standard planes of 9 (3x)2.8PosYesYes
223DYes43; 6; 6 and 143.1PosYesYes
233UYes116.2PosYesNo
243DYes63; 3; 6; 6; 6 and 114.0PosYesYes
251DYes43; 3; 4 and 64.6NegYesNo
261DYes45; 6; 6 and 65.6NegYesNo